eduKate Learning Manual
Science | Veterinary World
Define the Cell-Population Question → Preserve Viable Cells → Measure Size and Markers → Identify Immunophenotype → Compare With Morphology → Check Clonality and Tissue Context → Reassess

Veterinary Flow Cytometry

Why a Population of Similar Lymphocytes Is Not Automatically Lymphoma

Wait, What? A Machine Can Count Thousands of Similar Lymphocytes and Still Not Be Allowed to Call the Whole Disease by Itself

Flow cytometry is powerful because it can examine thousands of individual cells quickly. It can ask which surface or intracellular markers each cell expresses, how large the cells are, whether unusual marker combinations appear, and whether one population dominates the sample.

That sounds close to a diagnosis of lymphoma. Sometimes it strongly supports one. But “many similar lymphocytes” is still not the same scientific statement as “this animal has a fully classified lymphoma”. Reactive immune responses can expand particular lymphocyte populations. Sample quality can distort what reaches the machine. Some neoplastic populations resemble normal cells, and complete nodal lymphoma classification may require tissue architecture that flow cytometry cannot see.

immunophenotype describes the cells that were measured; diagnosis requires those cells to be placed back into the animal and tissue context.

The Scientific Job

This page owns one Veterinary World job:

How does veterinary flow cytometry characterise lymphoid and haematopoietic cell populations by physical properties and marker expression, and how should those findings be integrated with cytology, histopathology and molecular clonality before lymphoma or leukaemia is fully classified?

Veterinary Lymph Node Cytology retains morphological assessment of aspirated cells. Veterinary Cytology vs Histopathology retains the distinction between cell-level and tissue-architecture evidence. Veterinary Oncology retains the broader cancer framework. This page owns cell-population immunophenotyping by flow cytometry.

Quick Answer

Flow cytometry passes suspended cells one by one through lasers and records light scatter plus fluorescence from labelled antibodies. In veterinary medicine it is used mainly to immunophenotype haematopoietic neoplasms such as lymphoma and leukaemia. It can distinguish B-cell and T-cell populations, identify aberrant marker patterns and estimate cell size, but it complements rather than replaces morphology and tissue architecture.

A 2025 consensus from the Oncology-Pathology Working Group concluded that histopathology with immunohistochemistry is required for complete diagnosis and classification of primary nodal lymphomas in dogs, while immunohistochemistry and flow cytometry are the most reliable immunophenotyping methods and neither is clearly superior in every situation.

Explore 2025 OPWG Consensus — Diagnosis and Classification of Primary Nodal Lymphomas in Dogs →

Primary Entry — Flow Cytometry Sees Populations, Not Tissue Architecture

A lymph node aspirate can be converted into a suspension of individual cells. Those cells pass through the instrument in a narrow stream. Lasers illuminate them, detectors measure scattered light and fluorescent labels reveal which antigen markers are present.

The output is a map of cell populations. It can be extraordinarily detailed. Yet the cells have been removed from their original neighbourhood. The instrument cannot see whether lymph-node architecture is effaced, whether follicles are preserved, or how tumour cells invade tissue. Those are histopathological questions.

Part 1 — Forward and Side Scatter Are Clues About Cell Physical Properties

Flow cytometers record how light scatters as cells pass through the laser. Forward scatter broadly relates to cell size, while side scatter reflects internal complexity or granularity.

Large lymphoblast-like cells may therefore separate from smaller mature lymphocytes. But scatter is not a histological diagnosis. Instrument settings, cell viability and the biological diversity of lymphoid cells all influence the pattern.

Part 2 — Antibodies Reveal Immunophenotype

Fluorescent antibodies bind selected cell antigens. In dogs, commonly used marker combinations can help distinguish T-cell, B-cell and other haematopoietic lineages. The important concept is not memorising every CD number. It is understanding that a cell’s marker pattern provides evidence about lineage and differentiation.

A B-cell lymphoma and a T-cell lymphoma can look broadly similar on a low-resolution description such as “large lymphocytes”, yet their immunophenotypes are biologically different.

Part 3 — Immunophenotype Matters Clinically, but It Is Not the Entire Tumour Identity

Canine lymphomas are heterogeneous. B-cell versus T-cell lineage can carry prognostic and classification significance, but two B-cell lymphomas can still be biologically different diseases. Cell size, anatomical location, histological subtype, molecular features and clinical behaviour can all add information.

A study comparing flow cytometry, immunohistochemistry and PARR found high agreement between flow cytometry and immunohistochemistry for immunophenotyping of dogs already diagnosed with lymphoma. The important phrase is already diagnosed: immunophenotyping and diagnosis are related but not identical jobs.

Explore JVIM — Lymphoma Immunophenotype by IHC, Flow Cytometry and PARR →

Part 4 — Reactive Lymphocytes Can Expand Without Being Cancer

Immune stimulation can produce expansion of activated B or T cells. A reactive node can therefore contain populations that are not evenly mixed. Some cells can be large and activated. Some markers can shift with activation.

Flow cytometry becomes most convincing for neoplasia when the pattern is incompatible with ordinary reactive biology—for example, an aberrant immunophenotype, a dominant abnormal cell population or a combination of findings that agrees with malignant morphology. Even then, complete classification may require other evidence.

dominant population ≠ automatic malignancy; abnormal population + morphology + context = stronger inference.

Part 5 — Aberrant Antigen Expression Can Be More Informative Than Simple Lineage

Normal lymphocytes tend to express marker combinations appropriate to their lineage and stage of development. Neoplastic cells can lose expected markers, co-express unusual combinations or display an abnormal intensity pattern.

These aberrancies can make a neoplastic population easier to distinguish from the background of normal cells. But panel design matters: if the relevant marker is not included, the abnormality cannot be seen.

Secondary Deepening — The Sample Must Stay Alive Long Enough to Be Measured

Flow cytometry usually relies on intact viable cells. This creates a different preanalytical problem from histopathology, where formalin-fixed tissue can be preserved for long periods.

Delay, temperature, transport conditions, low cellularity and fragile neoplastic cells can change which cells survive to analysis. If a vulnerable tumour population dies preferentially, the final flow plot can underrepresent the disease.

This is why sample handling is part of the test, not an administrative detail.

eduKate Veterinary World — Veterinary Preanalytical Error

Part 6 — Cytology and Flow Cytometry Can Strengthen Each Other

Cytology shows cell morphology: nuclear size, chromatin, nucleoli, cytoplasm and population appearance. Flow cytometry adds objective cell-population measurements and marker expression.

A review of canine lymphoid neoplasia emphasises these correlations. Some lymphoma and leukaemia subtypes have characteristic morphological and flow-cytometric features, and interpretation is strongest when the two views agree.

Explore Veterinary Clinics — Lymphoid Neoplasia: Morphology and Flow Cytometry →

Part 7 — Histopathology Adds Architecture That Flow Cytometry Cannot Recover

Imagine emptying every person out of a school and analysing them individually. You could measure age, height, uniform and perhaps role. But you could no longer see which people were in classrooms, corridors or offices.

Flow cytometry does something similar to tissue. It gains high-dimensional single-cell information but loses spatial architecture. Histopathology restores that architecture, which is why the 2025 OPWG consensus retains histopathology with immunohistochemistry for complete primary nodal lymphoma classification in dogs.

Part 8 — PARR Answers a Different Question Again

PCR for antigen receptor rearrangements—often called PARR—asks whether lymphocytes show evidence of a clonally expanded antigen-receptor rearrangement. It can support a diagnosis of lymphoid neoplasia when morphology and immunophenotype remain uncertain.

But clonality is not the same as immunophenotype, and clonality is not synonymous with malignancy in every biological setting. The 2025 OPWG consensus specifically states that molecular clonality testing should not replace immunophenotyping for lymphoma classification.

JC Deepening — Flow Cytometry Is a Classification Problem in High-Dimensional Space

Each cell can be represented by several measurements: size, granularity and intensity of multiple markers. A population then becomes a cloud of points in a multidimensional space.

Interpretation involves deciding which clouds correspond to normal B cells, normal T cells, immature cells, neoplastic populations, dead cells or artefact. That decision is influenced by gating strategy, antibody performance, compensation, reference populations and disease biology.

more dimensions can improve separation, but they also create more ways to misclassify a poorly controlled sample.

Part 9 — Leukaemia Makes Blood and Bone Marrow Context Important

When abnormal lymphoid or myeloid cells circulate in blood, flow cytometry can help determine lineage and maturation pattern. Yet acute leukaemia, chronic leukaemia and lymphoma with blood involvement are not distinguished by one marker alone.

Blood counts, smear morphology, bone marrow findings, organ involvement and clinical course remain essential parts of the classification.

Part 10 — Cell Size Can Add Prognostic Information but Depends on Method

Flow cytometry can estimate relative cell size from light scatter. In some canine lymphoma subtypes, cell-size and antigen-expression features have prognostic associations.

But relative scatter depends on instrument settings and calibration. It should not be treated as a universal microscopic ruler across laboratories.

Part 11 — A Negative or Indeterminate Flow Result Does Not Erase Suspicious Morphology

A poor-quality sample can contain too few viable cells, or the tumour may express markers not adequately captured by the panel. Some neoplasms also show ambiguous phenotypes.

When strong clinical or morphological evidence persists, an indeterminate flow result should generate a next question rather than a false all-clear.

Part 12 — Flow Cytometry Is Best Used as Part of a Deliberate Diagnostic Sequence

A strong sequence is often: identify the abnormal tissue or blood population, describe morphology, preserve a viable sample when flow cytometry could answer a meaningful immunophenotype question, then use histopathology, immunohistochemistry or clonality testing when classification remains incomplete.

The order matters because every sample has finite material. Diagnostic planning before the sample is exhausted can preserve options.

How Do We Know?

The veterinary evidence base includes comparative studies of flow cytometry, immunohistochemistry and PARR; reviews of lymphoid neoplasia; clinical flow-cytometry guidance; and the 2025 Oncology-Pathology Working Group consensus on canine nodal lymphoma. The evidence supports flow cytometry as a highly useful immunophenotyping tool while maintaining a clear boundary between cell-population characterisation and complete tissue-level diagnosis.

Explore Veterinary Clinics 2023 — Flow Cytometry in Veterinary Practice →

Observation vs Inference

• Observation: most viable lymphocytes in a node express a B-cell phenotype and have increased scatter size.
• Inference: a B-cell lymphoproliferative disorder becomes more likely; complete lymphoma classification still requires morphology and context.
• Observation: a node contains a mixed population of B and T cells with activated morphology.
• Inference: reactive immune stimulation may be plausible; malignancy is not automatically excluded or confirmed.
• Observation: a dominant lymphocyte population expresses an unusual marker combination.
• Inference: aberrant immunophenotype strengthens suspicion of neoplasia.
• Observation: flow cytometry is indeterminate because few viable cells arrived.
• Inference: the test failed to resolve the question; the disease itself has not been shown absent.

Evidence Boundaries

• similar lymphocytes ≠ lymphoma automatically.
• B-cell or T-cell phenotype ≠ complete lymphoma subtype.
• dominant population ≠ malignancy proven.
• clonality ≠ immunophenotype.
• PARR ≠ replacement for immunophenotyping.
• flow cytometry ≠ tissue architecture.
• negative flow result ≠ neoplasia excluded when sample quality is poor.
• marker panel result ≠ independent of laboratory method.

Common Misconceptions

Misconception	Better model
Flow cytometry diagnoses every lymphoma by itself.	It is excellent for immunophenotyping but complete classification often needs morphology and architecture.
A monomorphic population is always malignant.	Reactive expansions and sampling effects can imitate restricted populations.
PARR and flow cytometry are interchangeable.	PARR measures clonality; flow cytometry measures phenotype and cell characteristics.
Indeterminate flow means normal.	It may mean the sample or marker panel could not answer the question.

Unfamiliar Transfer

Dog A has a lymph node full of large B-phenotype cells with an aberrant marker pattern and cytology strongly suspicious for lymphoma. Dog B has an enlarged node after vaccination with mixed activated B and T cells. Dog C has strongly suspicious cytology but an indeterminate flow result after delayed sample transport.

A strong learner does not let the instrument overrule the biology. The learner asks whether the sample was representative and viable, whether the phenotype fits the morphology, whether architecture is still needed and what uncertainty remains.

Checkpoint Questions

1. What does flow cytometry measure about individual cells?
2. What do forward and side scatter broadly represent?
3. What is immunophenotyping?
4. Why can reactive lymphocytes complicate interpretation?
5. What can aberrant antigen expression suggest?
6. Why is sample viability important?
7. What does histopathology add that flow cannot?
8. How is PARR different from flow cytometry?
9. Why can an indeterminate flow result fail to exclude lymphoma?
10. Why should flow results be interpreted with morphology?

Answer key

1. Light scatter and fluorescence from labelled cellular markers.
2. Relative cell size and internal complexity.
3. Classification of cells by lineage- and differentiation-associated antigen patterns.
4. Immune stimulation can expand activated populations without cancer.
5. A neoplastic population may have lost or gained marker patterns inconsistent with normal cells.
6. Dead or degraded cells can disappear or distort the measured population.
7. Tissue architecture and spatial relationships.
8. PARR measures antigen-receptor clonality, while flow measures cell phenotype.
9. The failure may be preanalytical or panel-related rather than biological absence.
10. The strongest diagnosis integrates independent views of the same disease.

Edge Science — From Small Marker Panels to High-Dimensional Single-Cell Oncology

Newer flow platforms can measure more markers per cell, and computational methods can detect population structures that are difficult to see on simple two-dimensional plots. Single-cell sequencing can add gene-expression and mutation information beyond surface phenotype.

The danger is seductive complexity. High-dimensional clustering can always find patterns. The scientific challenge is proving that a pattern is reproducible, biologically meaningful and useful for an animal’s diagnosis or prognosis. Future systems should preserve the raw cell populations and marker definitions rather than reducing everything to an unexplained label.

Veterinary World Direction Graph

Veterinary flow cytometry → abnormal lymphoid/haematopoietic population → viable sample → scatter and marker panel → immunophenotype → aberrancy assessment → morphology correlation → tissue architecture/clonality when needed → integrated classification → serial reassessment.

Research Sources and Further Reading

• 2025 OPWG Consensus — Diagnosis and Classification of Primary Nodal Lymphomas in Dogs
• Lymphoma Immunophenotype by IHC, Flow Cytometry and PARR
• Flow Cytometric Immunophenotyping to Refine Cytological Diagnosis of Canine Lymphoma
• Lymphoid Neoplasia — Correlations Between Morphology and Flow Cytometry
• Flow Cytometry in Veterinary Practice

Educational boundary: Suspected lymphoma or leukaemia requires veterinary diagnostic assessment and often specialist pathology. This manual explains test interpretation only. It does not provide chemotherapy selection, drug dosing, prognosis for an individual animal or treatment instructions.

Teaching Guide for Parents, Tutors and Teachers

For the people who teach because somebody depends on them.

Imagine emptying a school into a field and scanning every person’s uniform, height and ID badge. You could learn a great deal about who is present. But you would no longer know which classroom each person came from or how the school was organised.

measure the cells → identify the population → compare with morphology → restore tissue context → use clonality only for the question it answers → keep uncertainty visible.

The mastery target is a learner who appreciates both the extraordinary resolution of single-cell measurement and the equally important information lost when cells are removed from their tissue.